Michelle A Petri, MD, MPH
Disclosures: Consulting Fee-amgen,Consulting Fee-EMD Serono,Consulting Fee-Janssen Pharmaceuticals,Consulting Fee-Novartis AG,Consulting Fee-GlaxoSmithKline,Consulting Fee-astellas pharmaceuticals,Consulting Fee-Decision Resources,Consulting Fee-Medscape LLC,Consulting Fee-Momenta Pharmaceuticals, Inc.,Contracted Research-Exagen,Consulting Fee-Blackrock Pharmaceuticals,Consulting Fee-Qiagen,Contracted Research-AstraZeneca,Consulting Fee-UCB Pharmaceuticals,Consulting Fee-Glenmark Pharmaceuticals

Professor Michelle Petri, MD, MPH

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA


Michelle Petri is a Professor of Medicine in the Division of Rheumatology and Director of the Lupus Center at the Johns Hopkins University School of Medicine and Johns Hopkins Hospital in Baltimore, Maryland. She earned her medical degree from Harvard Medical School in Boston, Massachusetts, and completed her internship and residency in Internal medicine at Massachusetts General Hospital. Thereafter, Professor Petri completed her Postdoctoral Fellowship in Allergy, Immunology, and Rheumatology at the University of California, San Francisco. She subsequently earned her master’s in Public Health and Epidemiology from johns Hopkins University Bloomberg School of Public Health.

Professor Petri’s research focuses on several aspects of systemic lupus erythematosus (SLE), including atherosclerosis, antiphospholipid syndrome (APS), lupus nephritis, and pregnancy. The Hopkins Lupus Cohort, started by Professor Petri in 1987, is a longitudinal study of the incidence and pathogenesis of thrombotic events and coronary artery disease in SLE. Its serum and plasma bank is a useful resource for other SLE-related research. The Hopkins Lupus Pregnancy Center, of which Professor Petri is a Co-Director, has a database of over 400 pregnant patients, providing information on lupus activity, antiphospholipid tests, and pregnancy outcomes. As part of the Systemic Lupus International Collaborating Clinics, Hopkins participates in studies of atherosclerosis, malignancy, and neuropsychiatric lupus. Professor Petri has served as study Chair or Principal Investigator for several of these studies on the SLE patient population.

Professor Petri has authored over 400 papers and chapters on SLE and APS. She is on the editorial board of Arthritis and Rheumatism, The Journal of Rheumatology, and Journal of Clinical Rheumatology. Dr. Petri serves as an ad hoc reviewer for Annals of Internal Medicine, The American Journal of Medicine, Medicine, Lancet, JAMA, Southern Medical Journal, and Fertility and Sterility. She served on the Medical Advisory Board of the Lupus Foundation of America, is a member of the American College of Rheumatology, and was Chair of the Lupus Now Education Program.